The rationale of prevention of thrombosis by enhancing blood levels of single-chain urokinase-type plasminogen activator (scuPA)

G Dooijewaard, P A van Boheemen, D J Binnema, C Kluft

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)278-280
JournalAnnals of the New York Academy of Sciences
Volume667
DOIs
Publication statusPublished - 4 Dec 1992

Keywords

  • cardiovascular diseases
  • fibrinolysis
  • thrombosis

Cite this